Bioprocessing - Upstream & Downstream

Manufacture Advanced Medicine

06/05/2023 | Catherine Buchere, Kathrin Teschner | 7 min read

Understanding AAV production and characterization processes – and establishing strategies for success.

Discovery & Development Drug Discovery

05/11/2023 | Sponsored by Bio-Rad Laboratories | 6 min read

How increased biological understanding and advanced technology are generating new antibody-based modalities with exciting potential.

Manufacture Bioprocessing - Upstream & Downstream

05/03/2023 | Neha Mishra, Jesus Zurdo | 9 min read

How fucosylation-deficient CHO cell hosts can help enhance the potency of monoclonal antibody-based biotherapeutics

Business & Regulation Profession

04/17/2023 | Stephanie Sutton

The wait is over. Our annual celebration of the pharma industry’s most influential individuals has returned!

Manufacture Bioprocessing - Upstream & Downstream

04/05/2023 | Nandu Deorkar, Jungmin Oh, Pranav Vengsarkar, Jonathan Fura | 6 min read

From resins to buffers to single-use technologies – there are many opportunities to improve downstream processes.

Manufacture Bioprocessing - Upstream & Downstream

04/04/2023 | Adam Pinkert, Áine Brennan | 6 min read

How the thoughtful adoption of new technology can both problem-solve and future- proof critical processes in biomanufacturing

Manufacture Bioprocessing - Upstream & Downstream

03/07/2023 | Stephanie Sutton

A video interview discussing the challenges of viral vectors

Business & Regulation Business Practice

02/20/2023

Download our eBook to find out how the industry is trying to be more sustainable.

Manufacture Bioprocessing - Upstream & Downstream

02/14/2023 | Eric Rhodes | 4 min read

Why 2023 is the year that antibody manufacturers should embrace CRISPR gene editing.

Manufacture Advanced Medicine

12/27/2022 | Brian Mullan | 12 min read

Great successes are being seen in gene therapy, but there are still gaps in our scientific knowledge – and our manufacturing prowess.